Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.
from Latest Science News -- ScienceDaily https://ift.tt/2Kq8xtK
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment